<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0008383"><a href="http://purl.obolibrary.org/obo/MONDO_0008383">MONDO:0008383</a></h3>
<p><strong>Label:</strong> rheumatoid arthritis</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0011429">MONDO:0011429</a> (juvenile rheumatoid arthritis), <a href="http://purl.obolibrary.org/obo/MONDO_0018456">MONDO:0018456</a> (polyarticular juvenile idiopathic arthritis), <a href="http://purl.obolibrary.org/obo/MONDO_0019432">MONDO:0019432</a> (rheumatoid factor-negative juvenile idiopathic arthritis), <a href="http://purl.obolibrary.org/obo/MONDO_0019433">MONDO:0019433</a> (Oligoarticular juvenile idiopathic arthritis),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_92">Orphanet:92</a>, <a href="http://www.orpha.net/ORDO/Orphanet_85414">Orphanet:85414</a>, <a href="http://www.orpha.net/ORDO/Orphanet_404580">Orphanet:404580</a>, <a href="http://www.orpha.net/ORDO/Orphanet_85410">Orphanet:85410</a>, <a href="http://purl.obolibrary.org/obo/OMIM_604302">OMIM:604302</a>, <a href="http://www.orpha.net/ORDO/Orphanet_85408">Orphanet:85408</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) and <a href="http://purl.obolibrary.org/obo/HP_0025021">HP:0025021</a> (Abnormal erythrocyte sedimentation rate) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) and <a href="http://purl.obolibrary.org/obo/HP_0011227">HP:0011227</a> (Elevated C-reactive protein level) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) and <a href="http://purl.obolibrary.org/obo/HP_0011032">HP:0011032</a> (Abnormality of fluid regulation) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) and <a href="http://purl.obolibrary.org/obo/HP_0005681">HP:0005681</a> (Juvenile rheumatoid arthritis) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) and <a href="http://purl.obolibrary.org/obo/HP_0003565">HP:0003565</a> (Elevated erythrocyte sedimentation rate) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001386">HP:0001386</a> (Joint swelling) and <a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001370">HP:0001370</a> (Rheumatoid arthritis) and <a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000969">HP:0000969</a> (Edema) and <a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) and <a href="http://purl.obolibrary.org/obo/HP_0012531">HP:0012531</a> (Pain) and <a href="http://purl.obolibrary.org/obo/HP_0025021">HP:0025021</a> (Abnormal erythrocyte sedimentation rate) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) and <a href="http://purl.obolibrary.org/obo/HP_0011227">HP:0011227</a> (Elevated C-reactive protein level) and <a href="http://purl.obolibrary.org/obo/HP_0025142">HP:0025142</a> (Constitutional symptom) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) and <a href="http://purl.obolibrary.org/obo/HP_0011227">HP:0011227</a> (Elevated C-reactive protein level) and <a href="http://purl.obolibrary.org/obo/HP_0025021">HP:0025021</a> (Abnormal erythrocyte sedimentation rate) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) and <a href="http://purl.obolibrary.org/obo/HP_0011227">HP:0011227</a> (Elevated C-reactive protein level) and <a href="http://purl.obolibrary.org/obo/HP_0012531">HP:0012531</a> (Pain) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) and <a href="http://purl.obolibrary.org/obo/HP_0011227">HP:0011227</a> (Elevated C-reactive protein level) and <a href="http://purl.obolibrary.org/obo/HP_0011842">HP:0011842</a> (Abnormality of skeletal morphology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) and <a href="http://purl.obolibrary.org/obo/HP_0011032">HP:0011032</a> (Abnormality of fluid regulation) and <a href="http://purl.obolibrary.org/obo/HP_0012531">HP:0012531</a> (Pain) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003493">HP:0003493</a> (Antinuclear antibody positivity) and <a href="http://purl.obolibrary.org/obo/HP_0011032">HP:0011032</a> (Abnormality of fluid regulation) and <a href="http://purl.obolibrary.org/obo/HP_0011227">HP:0011227</a> (Elevated C-reactive protein level) 66.67%</li>
</ul>
</body>
</html>
